Cargando…

Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)

BACKGROUND: Digitalization and electronic health (eHealth) offer new treatment approaches for patients with migraine. Current smartphone applications (apps) for migraine patients include a wide spectrum of functions ranging from digital headache diaries to app-based headache treatment by, among othe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira Gonçalves, Ana Sofia, Laumeier, Inga, Hofacker, Maxi Dana, Raffaelli, Bianca, Burow, Philipp, Dahlem, Markus A., Heintz, Simon, Jürgens, Tim Patrick, Naegel, Steffen, Rimmele, Florian, Scholler, Simon, Kurth, Tobias, Reuter, Uwe, Neeb, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243352/ https://www.ncbi.nlm.nih.gov/pubmed/35785344 http://dx.doi.org/10.3389/fneur.2022.912288

Ejemplares similares

Determining the Evolution of Headache Among Regular Users of a Daily Electronic Diary via a Smartphone App: Observational Study
por: Raffaelli, Bianca, et al.
Publicado: (2021)

Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2021)

Plasma calcitonin gene‐related peptide (CGRP) in migraine and endometriosis during the menstrual cycle
por: Raffaelli, Bianca, et al.
Publicado: (2021)

The potential of lasmiditan in migraine
por: Mecklenburg, Jasper, et al.
Publicado: (2020)

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
por: Raffaelli, Bianca, et al.
Publicado: (2019)

Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary
por: Raffaelli, Bianca, et al.
Publicado: (2021)

Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
por: Overeem, Lucas Hendrik, et al.
Publicado: (2021)

Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study
por: Raffaelli, Bianca, et al.
Publicado: (2021)

Perception of typical migraine images on the internet: Comparison between a metropolis and a smaller rural city in Germany
por: Hamann, Till, et al.
Publicado: (2023)

Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary
por: Roesch, Aaron, et al.
Publicado: (2020)

Patients’ and Health Care Workers’ Perception of Migraine Images on the Internet: Cross-sectional Survey Study
por: Raffaelli, Bianca, et al.
Publicado: (2021)

Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
por: Raffaelli, Bianca, et al.
Publicado: (2020)

Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies
por: Terhart, Maria, et al.
Publicado: (2021)

Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
por: Raffaelli, Bianca, et al.
Publicado: (2022)

Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice
por: Storch, P., et al.
Publicado: (2021)

The influence of weather on migraine – are migraine attacks predictable?
por: Hoffmann, Jan, et al.
Publicado: (2015)

Vertebrobasilar artery elongation in migraine—a retrospective cross-sectional study
por: Hensel, Ole, et al.
Publicado: (2022)

Characteristics and diagnoses of acute headache in pregnant women – a retrospective cross-sectional study
por: Raffaelli, Bianca, et al.
Publicado: (2017)

The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
por: Burow, Philipp, et al.
Publicado: (2021)

Headache and migraine in mitochondrial disease and its impact on life—results from a cross-sectional, questionnaire-based study
por: Burow, Philipp, et al.
Publicado: (2021)

Medication adherence in patients with cluster headache and migraine: an online survey
por: Rimmele, Florian, et al.
Publicado: (2023)

Sex Hormones and Calcitonin Gene–Related Peptide in Women With Migraine: A Cross-sectional, Matched Cohort Study
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Migraine and Hormonal Contraception in Gynecological Outpatient Care—Cross-Sectional Study among Practicing Gynecologists in Germany
por: Fitzek, Mira P., et al.
Publicado: (2023)

Editorial: Spotlight on resistant and refractory migraine
por: Ornello, Raffaele, et al.
Publicado: (2023)

Two TRPV1 receptor antagonists are effective in two different experimental models of migraine
por: Meents, Jannis E, et al.
Publicado: (2015)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
por: Hong, Ja Bin, et al.
Publicado: (2023)

Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Naegel, Steffen, et al.
Publicado: (2010)

A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence
por: Benemei, Silvia, et al.
Publicado: (2020)

HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm
por: Oliveira Gonçalves, Ana Sofia, et al.
Publicado: (2021)

Serum tau protein elevation in migraine: a cross-sectional case–control study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Transient Localized Wave Patterns and Their Application to Migraine
por: Dahlem, Markus A, et al.
Publicado: (2013)

Migraine Aura: Retracting Particle-Like Waves in Weakly Susceptible Cortex
por: Dahlem, Markus A., et al.
Publicado: (2009)

Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts
por: Ruscheweyh, Ruth, et al.
Publicado: (2020)

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
por: Raffaelli, Bianca, et al.
Publicado: (2023)

EHMTI-0124. Central vestibular system modulation in vestibular migraine - a VBM study
por: Wurthmann, S, et al.
Publicado: (2014)

Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dt7k3ae7a3er3412ogn18i4dii